Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris

被引：0
|
作者：
Sator, PG
Schmidt, JB
Hönigsmann, H
机构：
[1] Lainz Hosp, Dept Dermatol & Venerol, Vienna, Austria
[2] Univ Vienna, Dept Special & Environm Dermatol, Gen Hosp, Vienna, Austria
来源：
EXPERIMENTAL DERMATOLOGY | 2003年 / 12卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [1] Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris -: A pilot study
    Sator, PG
    Schmidt, JB
    Hönigsmann, H
    [J]. DERMATOLOGY, 2003, 206 (03) : 241 - 248
  • [2] Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
    Lucky, AW
    Henderson, TA
    Olson, WH
    Robisch, DM
    Lebwohl, M
    Swinyer, LJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (05) : 746 - 754
  • [3] CLINICAL-EVALUATION OF A NEW TRIPHASIC ORAL-CONTRACEPTIVE - NORGESTIMATE AND ETHINYL ESTRADIOL
    GAUTHIER, A
    UPMALIS, D
    DAIN, MP
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 : 27 - 32
  • [4] Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate
    Schmitt-Hoffmann, A. H.
    Roos, B.
    Sauer, J.
    Schleimer, M.
    Schoetzau, A.
    Leese, P. T.
    Weidekamm, E.
    Maares, J.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 : 4 - 11
  • [5] CYCLE CONTROL WITH TRIPHASIC NORGESTIMATE AND ETHINYL ESTRADIOL, A NEW ORAL-CONTRACEPTIVE AGENT
    ANDOLSEK, KM
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 : 22 - 26
  • [6] Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate
    Schmitt-Hoffmann, A.
    Roos, B.
    Brown, T.
    Weidekamm, E.
    Leese, P. T.
    Man, A.
    [J]. EADV: PROCEEDINGS OF THE 15TH CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, : 589 - +
  • [7] The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women
    Zhang, Jenny
    Chung, Ellen
    Yones, Cynthia
    Persson, Anna
    Mahnke, Lisa
    Eley, Timothy
    Xu, Xiaohui
    Bertz, Richard
    [J]. ANTIVIRAL THERAPY, 2011, 16 (02) : 157 - 164
  • [8] PHARMACOKINETICS OF A TRIPHASIC ORAL-CONTRACEPTIVE CONTAINING DESOGESTREL AND ETHINYL ESTRADIOL
    ARCHER, DF
    TIMMER, CJ
    LAMMERS, P
    [J]. FERTILITY AND STERILITY, 1994, 61 (04) : 645 - 651
  • [9] Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea
    Grinspoon, SK
    Friedman, AJ
    Miller, KK
    Lippman, J
    Olson, WH
    Warren, MP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08): : 3651 - 3656
  • [10] Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate
    Bifano, Marc
    Sevinsky, Heather
    Hwang, Carey
    Kandoussi, Hamza
    Jiang, Hao
    Grasela, Dennis
    Bertz, Richard
    [J]. ANTIVIRAL THERAPY, 2014, 19 (05) : 511 - 519
12345